Official websites use .govA.govwebsite belongs to an official
                            government organization in the United States.

Secure .gov websites use HTTPSAlock(LockLocked padlock icon) orhttps://means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Following publication of the original article [1], the authors reported that the first sentence under the Study design and patients section needed to be updated. This minor revision does not change the experimental design, results, or conclusions of the study. Its sole purpose is to improve the clarity of the description and prevent any potential misinterpretation by the readers.

The ChTUIA study is a national, prospective, observational, multi-center registry that focusing on patients with UIA receiving any surgical treatment or endovascular treatment at 83 regional neurological medical centers across China, from December 2021 to December 2024 (Fig. 2).

The ChTUIA study is a national, prospective, observational, multi-center registry that focusing on patients with UIA receiving any surgical treatment or endovascular treatment at 83 regional neurological medical centers across China, conducting from December 2021 to December 2024 (Fig. 2). Eligible patients were continuously recruited between December 2021 and December 2022.